Species | Homo sapiens |
Species subgroup | |
Subgroup type | |
Sequence Name | IGHV4-59*i01 |
IUIS Name | |
Alternative names | IGHV4-59*p20 |
Affirmation Level | 1 |
Full Sequence | |
Coding Sequence | |
Functionality | F |
Inference Type | Rearranged Only |
Mapped | |
Paralogs | |
Paralog Rep |
Un-rearranged sequence observations that support this sequence:
Click here to review supporting data in VDJbase.
Clicking the link will take you to VDJbase. Open in a new tab if you want to keep this page open. In VDJbase, click on the count in the Apperances column to see a list of samples in which the sequence was found.
CDR1 Start | 76 |
CDR1 End | 99 |
CDR2 Start | 151 |
CDR2 End | 171 |
CDR3 Start | 286 |
Sequence ID | A00010 |
Curator | |
Curator address | Dept. of Immunotechnology, Lund University, Medicon Village building 406, S-22381 Lund, Sweden |
Version | 2 |
Release Date | 2019-04-12 |
Release Notes | A trailing “.” in the sequence indicates IARC’s opinion that the sequence is likely to contain additional 3’ nucleotides for which there is insufficient evidence to make an affirmation. |
Locus | IGH |
Sequence Type | V |
Gene Subgroup | 4 |
Gene Designation | 59 |
Allele Designation | i01 |
Gene start | 1 |
Gene end | 292 |
Notes are added by IARC reviewers.
This sequence represents IGHV4-59*01 T288C in terms of the IMGT numbering system. The committee noted a rearrangement frequency of about 1.7%, with 1515 alignments including 341 perfect matches to the inferred allele. IGHV4-59*01 is also present in the genotype and is represented by larger number of reads than IGHV4-59*01 T288C (ratio: 17:83). The S0007 submission noted that haplotyping was not possible, but MC indicated that it was possible to haplotype this individual using the IGHJ4 locus. He suggested that a previously unreported J4 allele was present in this individual, and agreed to send his analysis to members of the committee. Diverse reads representing the IGHV4-59*01 T288C inference have been submitted to SRA/ENA under accession numbers SRR8298738 and SRR8298744. All members of the committee agreed that the sequence should be accepted as a Level 1 sequence at IARC Meeting 31 on February 8th, 2019. In line with previous policy, the submitted sequence will be recognized up to and including nucleotide 319. (April 12, 2019) A trailing “.” in the sequence indicates IARC’s opinion that the sequence is likely to contain additional 3’ nucleotides for which there is insufficient evidence to make an affirmation. |
History logs the times and reasons for the publication of each version of this sequence.
Andrew Collins 2019-04-02 22:39:06 | Version 1 published Submission published by IARC on April 3, 2019 |
Mats Ohlin 2019-04-12 14:49:26 | Version 2 published A trailing “.” in the sequence indicates IARC’s opinion that the sequence is likely to contain additional 3’ nucleotides for which there is insufficient evidence to make an affirmation. |
v1 | v2 | |
---|---|---|
Notes | changed |
All published versions of this sequence.
Sequence Name | IMGT Name | Version | Date |
---|---|---|---|
IGHV4-59*i01 | 1 | 2019-04-02 | |
IGHV4-59*i01 | 2 | 2019-04-12 | |
IGHV4-59*i01 | IGHV4-59*12 | 3 | 2019-05-16 |
IGHV4-59*12 | IGHV4-59*12 | 4 | 2023-07-10 |